-+ 0.00%
-+ 0.00%
-+ 0.00%

XILIO THERAPEUTICS INC : LEERINK PARTNERS ADJUSTS TARGET PRICE TO $20 FROM $2 TO REFLECT 1-FOR-14 REVERSE STOCK SPLIT

Reuters·03/24/2026 12:28:50

Please log in to view news